Effects of personalized live-remote exercise for individuals living beyond primary curative cancer treatment: study protocol for a multinational, super umbrella randomized controlled trial (LION-RCT)
Authors
Mark Trevaskis (ORCID: https://orcid.org/0000-0002-9078-0180)
Wilhelm Bloch (ORCID: https://orcid.org/0000-0003-1786-8853)
Evelyn M. Monninkhof (ORCID: https://orcid.org/0000-0002-6641-7605)
Martijn M. Stuiver (ORCID: https://orcid.org/0000-0002-7794-7767)
David Binyam (ORCID: https://orcid.org/0000-0002-8708-9719)
Joachim Wiskemann (ORCID: https://orcid.org/0000-0002-5971-5436)
Jon Belloso
Anouk E. Hiensch (ORCID: https://orcid.org/0000-0002-6216-2609)
Laurien M. Buffart (ORCID: https://orcid.org/0000-0002-8095-436X)
Eva M. Zopf (ORCID: https://orcid.org/0000-0001-6250-0041)
Effects of personalized live-remote exercise for individuals living beyond primary curative cancer treatment: study protocol for a multinational, super umbrella randomized controlled trial (LION-RCT)
Mark Trevaskis, Wilhelm Bloch, Evelyn M. Monninkhof, Martijn M. Stuiver et al.
Journal
Trials
Topics
Cancer survivorship and care
article
Effects of personalized live-remote exercise for individuals living beyond primary curative cancer treatment: study protocol for a multinational, super umbrella randomized controlled trial (LION-RCT)
Mark Trevaskis, Wilhelm Bloch, Evelyn M. Monninkhof, Martijn M. Stuiver, David Binyam, Joachim Wiskemann, Jon Belloso, Anouk E. Hiensch, Laurien M. Buffart, Eva M. Zopf, Nadira Gunasekara, Anna Campbell, Alberto J. Alves, Sofia Viamonte, Martina E. Schmidt, Anne M. May, L. Heinrich, Ana Joaquim, Yvonne Wengström, Ander Urruticoechea, Helene Rundqvist, Moritz Schumann, Neil K. Aaronson, Lonneke van de Poll, Karen Steindorf, Elsken van der Wall, Jana Müller, Dorothea Clauss, Alina Kias
article en
Abstract
No abstract available for this paper.
Publication Tag
TrialsVol. 26(1)
Institutions
Karolinska University Hospital (SE), German Sport University Cologne (DE), Radboud University Nijmegen (NL), German Cancer Research Center (DE), Utrecht University (NL), Heidelberg University (DE), Edinburgh Napier University (GB), Chemnitz University of Technology (DE), University Hospital Heidelberg (DE), Radboud University Medical Center (NL), Karolinska Institutet (SE), The Netherlands Cancer Institute (NL), University Medical Center Utrecht (NL), Cabrini Hospital (AU), Administração Regional de Saúde de Lisboa e Vale do Tejo (PT), National Center for Tumor Diseases (DE), Hubrecht Institute for Developmental Biology and Stem Cell Research (NL), Osakidetza (ES), Escola de Negócios e Administração (PT), Centro Hospitalar de Vila Nova de Gaia (PT), Onkologikoa (ES), Instituto Superior da Maia (PT), Australian Catholic University (AU)